These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
547 related articles for article (PubMed ID: 27064482)
1. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force. Chubak J; Whitlock EP; Williams SB; Kamineni A; Burda BU; Buist DS; Anderson ML Ann Intern Med; 2016 Jun; 164(12):814-25. PubMed ID: 27064482 [TBL] [Abstract][Full Text] [Related]
2. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews. Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752 [TBL] [Abstract][Full Text] [Related]
3. Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Guirguis-Blake JM; Evans CV; Senger CA; O'Connor EA; Whitlock EP Ann Intern Med; 2016 Jun; 164(12):804-13. PubMed ID: 27064410 [TBL] [Abstract][Full Text] [Related]
4. Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force. Dehmer SP; Maciosek MV; Flottemesch TJ; LaFrance AB; Whitlock EP Ann Intern Med; 2016 Jun; 164(12):777-86. PubMed ID: 27064573 [TBL] [Abstract][Full Text] [Related]
5. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. Bibbins-Domingo K; Ann Intern Med; 2016 Jun; 164(12):836-45. PubMed ID: 27064677 [TBL] [Abstract][Full Text] [Related]
6. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force. Whitlock EP; Burda BU; Williams SB; Guirguis-Blake JM; Evans CV Ann Intern Med; 2016 Jun; 164(12):826-35. PubMed ID: 27064261 [TBL] [Abstract][Full Text] [Related]
7. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Dubé C; Rostom A; Lewin G; Tsertsvadze A; Barrowman N; Code C; Sampson M; Moher D; Ann Intern Med; 2007 Mar; 146(5):365-75. PubMed ID: 17339622 [TBL] [Abstract][Full Text] [Related]
8. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force. Wolff T; Miller T; Ko S Ann Intern Med; 2009 Mar; 150(6):405-10. PubMed ID: 19293073 [TBL] [Abstract][Full Text] [Related]
9. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: An updated systematic evidence review for the U.S. Preventive Services Task Force. Fortmann SP; Burda BU; Senger CA; Lin JS; Whitlock EP Ann Intern Med; 2013 Dec; 159(12):824-34. PubMed ID: 24217421 [TBL] [Abstract][Full Text] [Related]
10. Which Aspirin Dose and Preparation Is Best for the Long-Term Prevention of Cardiovascular Disease and Cancer? Evidence From a Systematic Review and Network Meta-Analysis. Lotrionte M; Biasucci LM; Peruzzi M; Frati G; Giordano A; Biondi-Zoccai G Prog Cardiovasc Dis; 2016; 58(5):495-504. PubMed ID: 26851562 [TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Rostom A; Dubé C; Lewin G; Tsertsvadze A; Barrowman N; Code C; Sampson M; Moher D; Ann Intern Med; 2007 Mar; 146(5):376-89. PubMed ID: 17339623 [TBL] [Abstract][Full Text] [Related]